FI980463A - A self-replicating vector for DNA immunization against HIV - Google Patents
A self-replicating vector for DNA immunization against HIV Download PDFInfo
- Publication number
- FI980463A FI980463A FI980463A FI980463A FI980463A FI 980463 A FI980463 A FI 980463A FI 980463 A FI980463 A FI 980463A FI 980463 A FI980463 A FI 980463A FI 980463 A FI980463 A FI 980463A
- Authority
- FI
- Finland
- Prior art keywords
- self
- against hiv
- immunization against
- dna immunization
- replicating vector
- Prior art date
Links
- 230000003053 immunization Effects 0.000 title 1
- 238000002649 immunization Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Plant Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- AIDS & HIV (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI980463A FI105105B (en) | 1998-02-27 | 1998-02-27 | A self-replicating DNA vector for immunization against HIV |
OA1200000232A OA11528A (en) | 1998-02-27 | 1999-02-26 | Self-replicating vector for DNA immunization against HIV. |
EP99906279A EP1056879A1 (en) | 1998-02-27 | 1999-02-26 | Self-replicating vector for dna immunization against hiv |
APAP/P/2000/001892A AP2000001892A0 (en) | 1998-02-27 | 1999-02-26 | Self-replicating vector for DNA immunization against HIV. |
RU2000122617/13A RU2232815C2 (en) | 1998-02-27 | 1999-02-26 | Self-replicating recombinant vector expressing hiv regulatory proteins, method for it preparing, dna-base vaccine containing indicated vector for immunization against hiv, method for hiv treatment or prophylaxis |
AU26266/99A AU2626699A (en) | 1998-02-27 | 1999-02-26 | Self-replicating vector for dna immunization against hiv |
CN99804629A CN1295623A (en) | 1998-02-27 | 1999-02-26 | Self-replicating vector for DNA immunication against HIV |
PCT/FI1999/000152 WO1999043841A1 (en) | 1998-02-27 | 1999-02-26 | Self-replicating vector for dna immunization against hiv |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI980463A FI105105B (en) | 1998-02-27 | 1998-02-27 | A self-replicating DNA vector for immunization against HIV |
FI980463 | 1998-02-27 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI980463A0 FI980463A0 (en) | 1998-02-27 |
FI980463A true FI980463A (en) | 1999-09-27 |
FI105105B FI105105B (en) | 2000-06-15 |
Family
ID=8551073
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI980463A FI105105B (en) | 1998-02-27 | 1998-02-27 | A self-replicating DNA vector for immunization against HIV |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1056879A1 (en) |
CN (1) | CN1295623A (en) |
AP (1) | AP2000001892A0 (en) |
AU (1) | AU2626699A (en) |
FI (1) | FI105105B (en) |
OA (1) | OA11528A (en) |
RU (1) | RU2232815C2 (en) |
WO (1) | WO1999043841A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI107737B (en) * | 1999-12-23 | 2001-09-28 | Atso Raasmaja | Plasmid for expression of the tyrosine hydroxylase gene in the brain |
FI116851B (en) | 2001-05-03 | 2006-03-15 | Fit Biotech Oyj Plc | Expression vector, its uses and process for its preparation and products containing it |
EP1279404A1 (en) * | 2001-07-26 | 2003-01-29 | Istituto Superiore di Sanità | Use of HIV-1 tat, fragments or derivatives thereof, to target or to activate antigen-presenting cells, to deliver cargo molecules for vaccination or to treat other diseases |
DK1506223T3 (en) | 2002-05-16 | 2006-04-10 | Bavarian Nordic As | Fusion protein of regulatory / accessory HIV proteins |
KR101471043B1 (en) * | 2009-01-08 | 2014-12-09 | 주식회사 바이오리더스 | Stable Constitutively High Expression Vector for Anti-HPV Vaccine and Lactic Acid Bacteria Transformed by Thereof |
US10246509B2 (en) * | 2011-10-17 | 2019-04-02 | Regeneron Pharmaceuticals, Inc. | Restricted immunoglobulin heavy chain mice |
CN109640946A (en) * | 2016-06-03 | 2019-04-16 | 天普大学-联邦高等教育系统 | The negative-feedback regu- lation of HIV-1 is carried out by gene editing strategy |
CN110747214B (en) * | 2019-03-13 | 2021-12-31 | 深圳市臻质医疗科技有限公司 | DNA fragment, mRNA-antibody fusion molecule with long-acting expression and cell specific binding capacity and preparation method thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1138897A (en) * | 1995-12-29 | 1997-07-28 | Estonian Biocentre | Episomal vector and uses thereof |
-
1998
- 1998-02-27 FI FI980463A patent/FI105105B/en not_active IP Right Cessation
-
1999
- 1999-02-26 WO PCT/FI1999/000152 patent/WO1999043841A1/en not_active Application Discontinuation
- 1999-02-26 CN CN99804629A patent/CN1295623A/en active Pending
- 1999-02-26 AU AU26266/99A patent/AU2626699A/en not_active Abandoned
- 1999-02-26 EP EP99906279A patent/EP1056879A1/en not_active Withdrawn
- 1999-02-26 RU RU2000122617/13A patent/RU2232815C2/en not_active IP Right Cessation
- 1999-02-26 AP APAP/P/2000/001892A patent/AP2000001892A0/en unknown
- 1999-02-26 OA OA1200000232A patent/OA11528A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AP2000001892A0 (en) | 2000-09-30 |
FI105105B (en) | 2000-06-15 |
EP1056879A1 (en) | 2000-12-06 |
OA11528A (en) | 2004-05-07 |
AU2626699A (en) | 1999-09-15 |
WO1999043841A1 (en) | 1999-09-02 |
RU2232815C2 (en) | 2004-07-20 |
FI980463A0 (en) | 1998-02-27 |
CN1295623A (en) | 2001-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1050254A1 (en) | Isolated instructions for isolated execution. | |
NO980288D0 (en) | gas phase polymerization process | |
DK1340600T3 (en) | A razor | |
ZA9811848B (en) | Vaccine. | |
ZA984969B (en) | Vaccine. | |
ZA988789B (en) | Vaccine. | |
AU147712S (en) | Case for a handtool | |
GB0222199D0 (en) | A guidance system | |
GB9826069D0 (en) | HIV vaccine | |
EE9900391A (en) | A new process | |
FI980463A (en) | A self-replicating vector for DNA immunization against HIV | |
GB0008582D0 (en) | DNA immunization vectors | |
HK1066255A1 (en) | A structural formwork member | |
DK1105498T3 (en) | HIV vaccine | |
DK0973760T3 (en) | Codaistatins A, B, C and D, a method for their preparation and use | |
ITMO990082A0 (en) | HOOK MEANS. | |
NL1004223A1 (en) | Pile formwork. | |
ITMI981384A1 (en) | VACCINE FOR HIV | |
EP1066398A4 (en) | Gpi-122, a novel glycophosphatidylinositol-anchored protein | |
GB0031135D0 (en) | Novel polymerisation catalystis | |
IT1314233B1 (en) | VACCINE FOR HIV. | |
GB9703202D0 (en) | HIV vaccine | |
GB9725241D0 (en) | Hiv vaccine | |
IT1292652B1 (en) | HEAT RECOVERY HEAT RECOVERY. | |
DK1068182T3 (en) | Process for preparing a protected 4-aminomethylpyrrolidin-3-one |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |